ZINC00640089 is a specific Lipocalin-2 (LCN2) inhibitor. ZINC00640089 inhibits cell proliferation, cell viability and reduces AKT phosphorylation levels in SUM149 cells. ZINC00640089 has good potential for research in inflammatory breast cancer (IBC).
性状
Solid
IC50 & Target[1][2]
LCN2.
体外研究(In Vitro)
ZINC00640089 (0.01-100 μM; 72 h) reduces cell proliferation and cell viability in SUM149 cells.ZINC00640089 (1, 10 μM; 15 min, 1 h) reduces the p-Akt levels in SUM149 cells. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Viability Assay
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;4°C 2 years
参考文献
[1]. Santiago-Sánchez GS, et al. Targeting Lipocalin-2 in Inflammatory Breast Cancer Cells with Small Interference RNA and Small Molecule Inhibitors. Int J Mol Sci. 2021 Aug 10;22(16):8581.